Cumulative U.S. – based Myeloma Patient Population | Create infographics
With a disease as complex as myeloma, a large patient volume offers distinct advantages.
- Our large patient volume supports a program of clinical trials that enable patients to benefit from innovative, cutting-edge care.
- Our large patient volume supports statistical validity of data. We have a comprehensive database with detailed baseline and follow-up information that is unsurpassed and is used to predict patient outcome.
- Our staff is truly focused on the treatment of patients with multiple myeloma and related diseases. Physicians, nurses and other members of our patient care team are thoroughly familiar with treatment processes and the sequence of treatments, and are skilled at anticipating and recognizing potential complications and addressing patient and family needs.
Our Academic Home
The Myeloma Institute is a Chancellor’s Center of Excellence at the University of Arkansas for Medical Sciences (UAMS). The UAMS Campus includes a 350-bed teaching hospital, the Jackson T. Stephens Spine & Neurosciences Institute, the Winthrop P. Rockefeller Cancer Institute, the Harvey and Bernice Jones Eye Institute, the Outpatient Center, and the Donald W. Reynolds Center on Aging. UAMS is the only academic medical center in the state. It includes Colleges of Medicine, Nursing, Health Professions, Pharmacy, and Public Health, as well as a Graduate School. Myeloma Institute physicians are faculty members of the UAMS College of Medicine.
The Myeloma Institute is housed in the Winthrop P. Rockefeller Cancer Institute (Cancer Institute). Filled with natural light, the Cancer Institute environment promotes comfort and convenience for patients, caregivers and families, and collaboration opportunities for physicians, scientists and other health care professionals.
The Myeloma Institute’s research laboratories feature the latest and most scientifically sophisticated equipment.
A 30-bed inpatient unit in the hospital is dedicated to the multiple myeloma/stem cell transplant service. Spacious rooms include large picture windows and comfortable seating for family members and caregivers. Specially trained nursing and support staff meet the individual needs of each patient.
The Myeloma Institute Advisory Board
The Myeloma Institute Advisory Board assists the Myeloma Institute with cultivating the resources necessary to expand its clinical, research, and educational programs focused on continued development of curative therapies for multiple myeloma and related diseases.
Carol Ammon of Wilmington, Delaware, serves as chairman of the board. Read more about the advisory board.